Ransom Advisory’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$15.2K Sell
150
-50
-25% -$4.01K 0.01% 319
2025
Q3
$10.9K Hold
200
﹤0.01% 246
2025
Q2
$10.6K Hold
200
0.01% 273
2025
Q1
$8.66K Hold
200
﹤0.01% 286
2024
Q4
$11.2K Hold
200
0.01% 338
2024
Q3
$13.6K Hold
200
0.01% 332
2024
Q2
$8.45K Hold
200
﹤0.01% 353
2024
Q1
$13.8K Buy
+200
New +$12.7K 0.01% 269

Other funds holding EXAS

Ransom Advisory's EXAS Position: Q4 2025 in Review

Ransom Advisory reduced its Exact Sciences (EXAS) stake by 25% in Q4 2025, selling an estimated $4.01K and leaving 150 shares worth $15.2K. The position accounts for 0.01% of the portfolio, ranked #319.

Ransom Advisory first reported a position in EXAS in Q1 2024 and has held it in 8 quarters since. 710 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Ransom Advisory held 150 shares of Exact Sciences worth $15.2K as of Q4 2025.
  • Ransom Advisory sold 50 Exact Sciences shares in Q4 2025, an estimated $4.01K.
  • Exact Sciences made up 0.01% of Ransom Advisory's portfolio in Q4 2025, its #319 holding.
  • Ransom Advisory first reported a position in Exact Sciences in Q1 2024 and has held it in 8 quarters since.
  • 710 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.